StonvexLoading…
StonvexStonvexStonvexCore line items from NEM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $22.67B | $18.68B | $11.81B | $11.91B |
Operating Income | $11.34B | $4.58B | $-2.03B | $-51.00M |
Net Income | $7.08B | $3.35B | $-2.49B | $-429.00M |
EPS (Diluted) | $6.39 | $2.92 | $-2.97 | $-0.54 |
Total Assets | $57.12B | $56.35B | $55.51B | $38.48B |
Total Liabilities | $23.08B | $26.24B | $26.30B | $18.95B |
Cash & Equivalents | $7.65B | $3.62B | $3.00B | $2.88B |
Free Cash Flow OCF − CapEx | $7.30B | $2.96B | $97.00M | $1.09B |
Shares Outstanding | 1.09B | 1.13B | 1.15B | 793.00M |